Gemmer Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-151
| Closed | -$1K | – | 1310 |
|
2017
Q2 | $1K | Hold |
151
| – | – | ﹤0.01% | 1236 |
|
2017
Q1 | $1K | Hold |
151
| – | – | ﹤0.01% | 1220 |
|
2016
Q4 | $1K | Hold |
151
| – | – | ﹤0.01% | 1202 |
|
2016
Q3 | $1K | Hold |
151
| – | – | ﹤0.01% | 1211 |
|
2016
Q2 | $1K | Hold |
151
| – | – | ﹤0.01% | 1226 |
|
2016
Q1 | $0 | Hold |
151
| – | – | ﹤0.01% | 1334 |
|
2015
Q4 | $1K | Hold |
151
| – | – | ﹤0.01% | 1250 |
|
2015
Q3 | $1K | Hold |
151
| – | – | ﹤0.01% | 1240 |
|
2015
Q2 | $2K | Sell |
151
-35
| -19% | -$464 | ﹤0.01% | 1206 |
|
2015
Q1 | $2K | Buy |
186
+35
| +23% | +$376 | ﹤0.01% | 1244 |
|
2014
Q4 | $2K | Hold |
151
| – | – | ﹤0.01% | 1205 |
|
2014
Q3 | $2K | Hold |
151
| – | – | ﹤0.01% | 1206 |
|
2014
Q2 | $2K | Hold |
151
| – | – | ﹤0.01% | 1236 |
|
2014
Q1 | $3K | Buy |
+151
| New | +$3K | ﹤0.01% | 1100 |
|